Dr. Jitendra Singh meets SKIMS chief on diabetes research
Synopsis
Key Takeaways
Where science policy meets clinical frontlines, Union Science and Technology Minister Dr. Jitendra Singh sat down with one of Jammu and Kashmir's foremost endocrinologists on Friday, August 14, 2026 — a quiet but purposeful exchange that signals the Centre's continued attention to non-communicable disease research in the region.
SKIMS Director brings diabetes research agenda to the table
Dr. Mohammad Ashraf Ganie, Director of the Sher-i-Kashmir Institute of Medical Sciences (SKIMS) in Soura, Srinagar, called on Dr. Jitendra Singh to discuss recent research projects in the field of Diabetes and Metabolic Disorders. Dr. Ganie, a Professor of Endocrinology and a long-standing professional colleague of the Minister, leads one of the region's premier tertiary care and research institutions.
SKIMS has long been the anchor of advanced medical education and research in Jammu and Kashmir, and Dr. Ganie's specialisation in endocrinology places him at the centre of a growing national health challenge — India now carries one of the largest diabetes burdens in the world.
A meeting shaped by national health priorities
The engagement fits a broader pattern of the Science and Technology Ministry maintaining active dialogue with regional medical institutes on non-communicable disease research. Bodies such as ICMR and the Department of Biotechnology (DBT) have channelled funding toward state-level centres for exactly this kind of work — diabetes, metabolic syndrome, and related conditions that disproportionately affect populations across the subcontinent.
India's National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS), launched in 2010, laid the policy foundation for this push. Meetings like this one are where that policy framework meets ground-level research reality.
Whether the discussion translates into collaborative research grants or expanded SKIMS projects under national health research schemes will be worth watching in the weeks ahead — but the conversation has clearly begun.